Abstract
Toxic agents in bacterial cultures have been discov ered in the last decades of the nineteenth century. Pfeiffer described endotoxic in addition to exotoxic activities (Pfeiffer 1892), which include fever (Centanni 1942) and other deleterious effects. Between 1930 and 1940 the first efforts to isolate and enrich biologically active fragments of gram-negative bacteria were successful (Boivin and Mesrobeaunu 1935; Morgan 1937; Goebel et al. 1945) and by the work of Lüderitz and Westphal the endotoxically active material was determined to be a lipopolysaccharide (LPS) (Hartwell and Shear 1943). With the development of the hot phenol/water method (Westphal et al. 1952) the purification of LPS was improved, yielding purified LPS free of nuclei acid and protein. Subsequently, the lipid portion of the LPS molecule was proposed to be responsible for its endotoxic properties, and the term “lipid A” was introduced (Westphal and Lüderitz 1954). In the following three decades, this hypothesis was proven to be correct by the isolation of purified free lipid A, its structural elucidation, and finally the com plete chemical synthesis of lipid A. Detailed com parative investigations of natural and synthetic lip id A showed (1) that the chemical structure as de termined by analytical chemistry was correct and (2) that the biological activity of both natural and synthetic compounds was identical in various in vitro and in vivo biological test systems. At the same time, the successful chemical synthesis (Kusumoto et al. 1990) of lipid A partial structures and analogues allowed us to start investigations on structure-function relationships with regard to en dotoxic and beneficial effects of LPS.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Beutler B, Milsark IW, Cerami AC (1985) Passive immu nization against cachectin/tumor necrosis factor pro tects mice from lethal effect of endotoxin. Science 29:869–871.
Billiau A, Heremans H, Vandekerckhove F, Dillen C (1987) Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol 17:1851–1854.
Boivin A, Mesrobeaunu L (1935) Recherches sur les an tig’s somatiques et sur les endotoxines des bac téries. I. Consid é rations g é n é rales et expos é des tech niques utilis é es. Rev Immunol (Paris) 1:553–569.
Centanni E (1942) Immunitätserscheinungen im experi mentellen Fieber mit besonderer Berücksichtigung des pyrogenen Stoffes aus Typhusbazillen. Dtsch Med Wochenschr 20:148–152.
Cybulsky MI, McComb DJ, Movat HZ (1988) Neutro phil leukocyte emigration induced by endotoxin: me diator roles of interleukin 1 and tumor necrosis fac tor. J Immunol 140:3144–3149.
Feist W, Ulmer AJ, Musehold J, Brade H, Kusumoto S, Flad H-D (1989) Induction of tumor necrosis factoralpha release by lipopolysaccharide and defined LPS partial structures. Immunobiology 179:293–307.
Feist W, Ulmer AJ, Wang M-H, Musehold J, Schlüter C, Gerdes J, Brade H, Kusumoto S, Diamantstein T, Dinarello CA, Rietschel ET, Flad H-D (1992) Modu lation of lipopolysaccharide induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A. FEMS Microbiol Immunol 89:73–90.
Flad H-D, Loppnow H, Feist W, Wang MH, Brade H, Kusumoto S, Rietschel ET, Ulmer AJ (1989) Inter leukin 1 and tumor necrosis factor: studies on the in duction of lipopolysaccharide partial structures. Lymphokine Res 8:235–238.
Freudenberg MA, Galanos C (1988) Induction of toler ance to lipopolysaccharide-D-galactosamine lethality by pretreatment with LPS is mediated by macro phages. Infect Immun 56:1352–1357.
Galanos C, Freudenberg MA (1990) Tumor necrosis fac tor mediates endotoxin shock: the protective effects of antibodies and cortisone. In: Bonavida B, Granger G (eds) Tumor necrosis factor: structure, mechanism, action, role in disease and therapy. Karger, Basel, pp 187–193.
Galanos C, Lehmann V, Lüderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg MA, HansenHagge T, Lüderitz T, McKenzie G, Schade U, Strittmatter W, Tanamoto K-I, Zähringer U, Imoto N, Yoshimura H, Yamamoto M, Shimamoto T, Kusumoto S, Shiba T (1984) Endotoxic properties of chemically synthesized lipid A part structures. Com parison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem 140:221–227.
Galanos C, Lüderitz O, Rietschel ET, Westphal O, Brade H, Brade L, Freudenberg M, Schade U, Imoto M, Yoshimura H, Kusumoto S, Shiba T (1985) Synthetic and natural E. coli free lipid A express identical en dotoxic activities. Eur J Biochem 148:1–5.
Gillis S, Ferm MM, Ou W, Smith KA (1978) T-cell growth factor: parameters for production and a quantitative microassay for activity. J Immunol 120:2027–2032.
Goebel WF, Binkley F, Perlman E (1945) Studies on the Flexner group of dysenter bacilli. I. The specific anti gens of Shigellaparadysenteriae (Flexner). J Exp Med 81:315–358.
Hartwell JL, Shear MJ (1943) Nature of the hemor rhage-producing fraction from Serratia marcescens (Bac. prodigious) culture filtrate. J Natl Cancer Inst 4:107–122.
Hogg N (1989) The leukocyte integrins. Immunol Today 10:111–114.
Homma J, Matsuura M, Kanegasaki S, Kawakubo Y, Kojima Y, Shibukawa S, Kumazawa Y, Yamamoto A, Tanamoto K, Yasuda T, Imoto M, Yoshimura H, Kusumoto S, Shiba T (1985) Structural requirements of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem 98:395–406.
Jiao B, Freudenberg M, Galanos C (1989) Characteriza tion of the lipid A component of genuine smooth-form lipopolysaccharide. Eur J Biochem 180: 515–518.
Kanegasaki S, Tanamoto K-I, Yasuda T, Homma JY, Matsuura M, Nakatsuka M, Kumazawa Y, Yamamoto A, Shiba T, Kusumoto S, Imoto M, Yoshimura H, Shimamoto T (1986) Structure activity relationship of lipid A: comparison of biological activities of natural and synthetic lipid A’s with different fatty acid com position. J Biochem 99:1203–1210.
Kirikae T, Kirikae F, Schade FU, Yoshida M, Kondo S, Hisatsune K, Nishikawa S-I, Rietschel ET (1991) De tection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell lines. FEMS Microbiol Immunol 76:327–336.
Kovach NL, Yee E, Munford RS, Raetz CRH, Harlan JM (1990) Lipid IVa inhibits synthesis and release of tu mor necrosis factor induced by lipopolysaccharide in human blood ex vivo. J Exp Med 172:77–84.
Kusumoto S, Kamikawa T, Kurosawa M, Fukase K, Shiba T (1990) New results in the synthesis of lipid A and endotoxins. In: Nowotny A, Spitzer J, Zieler E (eds) Proceedings of the first congress of the International Endotoxin Society. Abstract L3, p 1.
Lam C, Hildebrandt J, Schütze E, Rosenwirth B, Proctor RA, Liehl E, Stütz P (1991) Immunostimulatory, but not antiendotoxin activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun 59:2351–2358.
Lebbar S, Cavaillon J-M, Caroff M, Ledur A, Brade H, Sarfati R, Haeffner-Cavaillon N (1986) Molecular re quirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol 16:87–91.
Libby P, Loppnow H, Girard J (1989) The roles of en dothelial cells in septic shock. In: Beaufils F, Mercier JC (eds) Chocs septiques en pediatrie. Arnette, Paris, pp 25–31.
Libby P, Loppnow H, Fleet JC, Palmer H, Li HM, Warner SJC, Salomon RN, Clinton SK (1990) Pro duction of cytokines by vascular cells — an update and implications for atherogenesis. In: Gottlieb AI, Langille BL, Federoff P (eds) Atherosclerosis: cellular and molecular interactions in the artery wall. Plenum, New York, pp 161–169.
Lindberg AA, Weintraub A, Zähringer U, Rietschel ET (1990) Structure-activity relationships in lipolysac charides of Bacteroides fragilis. Rev Infect Dis 12:133–141.
Loppnow H, Libby P (1989a) Adult human vascular en dothelial cells express the IL-6 gene differentially in response to LPS of IL-1. Cell Immunol 122:493–503.
Loppnow H, Libby P (1989b) Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. Lymphokine Res 8:293–299.
Loppnow H, Libby P (1990) Proliferating or interleukin 1-activated human vascular smooth muscle cells se crete copious interleukin 6. J Clin Invest 85:731–738.
Loppnow H, Libby P (1991) Functional significance of smooth muscle cell derived interleukin 1. Exp Cell Res 198:283–290.
Loppnow H, Brade L, Brade H, Rietschel ET, Kusumoto S, Shiba T, Flad H-D (1986) Induction of human interleukin-1 by bacterial and synthetic lipid A. Eur J Immunol 16:1263–1267.
Loppnow H, Brade H, Dürrbaum I, Dinarello CA, Kusumoto S, Rietschel ET, Flad H-D (1989) IL-1 in duction capacity of defined lipopolysaccharide par tial structures. J Immunol 142:3229–3238.
Loppnow H, Libby P, Freudenberg MA, Krauss JH, Weckesser J, Mayer H (1990) Cytokine induction by LPS corresponds to lethal toxicity and is inhibited by “non-toxic” Rhodobacter capsulatus LPS. Infect Im mun 58:3743–3750.
Lüderitz O, Westphal O, Staub AM, Nikaido H (1971) Isolation and chemical and immunological character ization of bacterial lipopolysaccharides. In: Weinbaum G, Kadis S, Ajl SJ (eds) Microbial toxins. Aca demic, New York, pp 145–233.
Mathison JC, Wolfson E, Ulevitch RJ (1988) Participa tion of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 81:1925–1937.
Morgan WTJ (1937) Studies in immunochemistry. II. The isolation and properties of a specific antigenic substance from B. dysenteriae. Biochem J 31: 2003–2021.
Movat HZ, Burrowes CE, Cybulski MI, Dinarello CA (1987) Acute inflammation and a Shwartzman-like re action induced interleukin 1 and tumor necrosis fac tor: synergistic action of the cytokines in the induc tion of inflammation and microvascular injury. Am J Pathol 129:463–476.
Munford RS, Hall CL (1986) Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutro phil enzyme. Science 234:203–205.
Newton RC (1986) Human monocyte production of in terleukin 1: parameters of the induction of IL-1 secre tion by lipopolysaccharide. J Leukoc Biol 39: 299–311.
Nishijama M, Amano F, Akamatsu Y, Akagawa K, Tokunaga T, Raetz CRH (1985) Macrophage activa tion by monosaccharide precursors of E. coli lipid A. Proc Natl Acad Sci USA 82:282–286.
Nogare AR, Yarbrough WC (1990) A comparison of the effects of intact and deacylated lipopolysaccharides on human polymorphonuclear leukocytes. J Immu nol 144:1404–1410.
Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson RC (1990) IL-1 receptor antagonist reduc es mortality from endotoxin shock. Nature 248: 550–552.
Pfeiffer R (1892) Untersuchungen über das Choleragift. Z Hyg 11:393–412.
Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70:427–451.
Pohlmann TH, Munford RS, Harlan JM (1987) Deacylated lipopolysaccharide inhibits neutrophil ad herence to endothelium induced by lipopolysac charide in vitro. J. Exp Med 165:1393–1402.
Qureshi N, Takayama K, Kurz R (1991) Diphosphoryl lipid A obtained from the nontoxic lipopolysac charide of Rhodopseudomonas sphaeroides is an en dotoxin antagonist in mice. Infect Immun 59: 441–444.
Raetz CRH (1990) Biochemistry of endotoxins. Annu Rev Biochem 59:129–170.
Riedo FX, Munford RS, Campbell WB, Reisch JS, Chien KR, Gerard RD (1990) Deacylated lipopolysaccharide inhibits plasminogen activator inhibitor-1, prosta cyclin, and prostaglandin E2 production by lipopoly saccharide but not by tumor necrosis factor. J Im munol 144:3506–3512.
Rietschel ET, Brade H, Brade L, Kawahara K, Lüderitz T, Schade U, Tacken A, Zähringer U (1986) Lipid A, the endotoxic principle of bacterial lipopolysac charides: chemical structure and biological activity. In: Seidl PH, Schleifer KH (eds) Biological properties of peptidoglycan. De Gruyter, Berlin, pp 341–352.
Rietschel ET, Brade L, Brandenburg K, Flad H-D, De Jong-Leuveninck J, Kawahara K, Lindner B, Loppnow H, Lüderitz T, Schade U, Seydel U, Sidorczyk Z, Tacken A, Zähringer U, Brade H (1987) Chemical structure and biologic activity of bacterial and syn thetic lipid A. Rev Infect Dis 9:527–536.
Rietschel ET, Brade L, Schade U, Seydel U, Zähringer U, Loppnow H, Flad H-D, Brade H (1989) Bacterial en dotoxins: relationships between chemical structure and biological activity. In: Gregoriadis G, Allison AC, Poste G (eds) Immunological adjuvants and vac cines. Plenum, New York, pp 61–74.
Sayers TJ, Macher I, Chung J, Kugler E (1987) The pro duction of tumor necrosis factor by mouse bone mar row-derived macrophages in response to bacterial lipopolysaccharide and a chemically synthesized mo nosaccharide precursor. J Immunol 138:2935–2940.
Takayama K, Qureshi N, Beutler B, Kirkland TN (1989) Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 17023 blocks induction of cachectin in macrophages by lipopolysaccharide. Infect Im mun 57:1336–1338.
Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/ TNF antibodies prevent septic shock during lethal bacteremia. Nature 330:662–664.
Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA (1991) A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits. FASEB J 5:338–343.
Wang M-H, Feist W, Herzbeck H, Brade H, Kusumoto S, Rietschel ET, Flad H-D, Ulmer AJ (1990) Suppres sive effect of lipid A partial structures on lipopolysac charide or lipid A-induced release of interleukin 1 by human monocytes. FEMS Microbiol Immunol 64: 179–186.
Wang M-H, Flad H-D, Feist W, Brade H, Kusumoto S, Rietschel ET, Ulmer AJ (1991) Inhibition of endotoxin-induced interleukin 6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. Infect Immun 59:4655–4664.
Wang M-H, Flad H-D, Feist W, Musehold J, Kusumoto S, Brade H, Gerdes J, Rietschel ET, Ulmer AJ (1992) Inhibition of endotoxin or lipid A induced TNF pro duction by synthetic lipid A partial structures in hu man peripheral blood mononuclear cells. Lymphokine Cytokine Res 11:23–31.
Westphal O, Lüderitz O (1954) Chemische Erforschung von Lipopolysacchariden Gram-negativer Bakterien. Angew Chem 66:407–417.
Westphal O, Lüderitz O, Bister F (1952) Ϝ ber die Extrak tion von Bakterien mit Phenol/Wasser. Z Natur forsch 7b:148.
Westphal O, Lüderitz O, Galanos C, Mayer H, Rietschel ET (1985) The story of bacterial endotoxin. In: Chedid L, Hadden JW, Spreafico F, Dukor P, Willoughby D (eds) Advances in immunopharmacology, proceedings of the 3rd international conference on immunopharmacology (Florence, Italy, 6–9 May). Pergamon, New York, pp 13–34.
Wright SD (1991) Multiple receptors for endotoxin. Curr Opin Cell Biol 3:83–90.
Yong K, Khwaja A (1990) Leukocyte cellular adhesion molecules. Blood Rev 4:211–225.
Zabel P, Wolter DT, Schönharting M, Schade UF (1989) Oxpentifylline in endotoxaemia. Lancet 2:1474–1477.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Loppnow, H., Flad, HD., Rietschel, E.T., Brade, H. (1993). The Active Principle of Bacterial Lipopolysaccharides (Endotoxins) for Cytokine Induction. In: Schlag, G., Redl, H. (eds) Pathophysiology of Shock, Sepsis, and Organ Failure. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76736-4_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-76736-4_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76738-8
Online ISBN: 978-3-642-76736-4
eBook Packages: Springer Book Archive